Tovinontrine
- Generic Name
- Tovinontrine
- Drug Type
- Small Molecule
- Chemical Formula
- C21H26N6O2
- CAS Number
- 2062661-53-2
- Unique Ingredient Identifier
- W248Y1AKOR
- Background
Tovinontrine is an orally administered, highly selective phosphodiesterase 9 (PDE9) small molecule inhibitor. Tovinontrine is under investigation in clinical trial NCT04474314 (A Study of IMR-687 in Subjects With Sickle Cell Disease).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath